Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Treasury Shares (2020 - 2025)

Merit Medical Systems' Treasury Shares history spans 6 years, with the latest figure at $378000.0 for Q4 2025.

  • For Q4 2025, Treasury Shares fell 36.47% year-over-year to $378000.0; the TTM value through Dec 2025 reached $378000.0, down 36.47%, while the annual FY2025 figure was $378000.0, 36.47% down from the prior year.
  • Treasury Shares for Q4 2025 was $378000.0 at Merit Medical Systems, down from $595000.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $595000.0 in Q4 2024 and bottomed at $20000.0 in Q4 2023.
  • The 5-year median for Treasury Shares is $179000.0 (2022), against an average of $239600.0.
  • The largest annual shift saw Treasury Shares tumbled 88.83% in 2023 before it skyrocketed 2875.0% in 2024.
  • A 5-year view of Treasury Shares shows it stood at $26000.0 in 2021, then surged by 588.46% to $179000.0 in 2022, then crashed by 88.83% to $20000.0 in 2023, then surged by 2875.0% to $595000.0 in 2024, then crashed by 36.47% to $378000.0 in 2025.
  • Per Business Quant, the three most recent readings for MMSI's Treasury Shares are $378000.0 (Q4 2025), $595000.0 (Q4 2024), and $20000.0 (Q4 2023).